Clinical trial ACTRN12624001303538
Status: Recruiting (according to the registry)Phase 3Latest change: Source: ANZCTR (Australia, New Zealand) (via WHO ICTRP)
What's on this page?
Information in the record
Original title: The CanOPY Study: The efficacy of cannabidiol in addition to standard treatment in first episode psychosis in young people
- Record number
- ACTRN12624001303538
- Registry
- ANZCTR (Australia, New Zealand) (via WHO ICTRP)
- Status
- Recruiting (according to the registry)
- Type and phase
- Clinical trial, phase 3
- Participants
- Target: 200
- Condition (as registered)
- First episode psychosis, Mental Health - Psychosis and personality disorders
- Countries
- Australia
- Topic in the guide
- Schizophrenia
Timeline
According to the ANZCTR (Australia, New Zealand) (via WHO ICTRP) record. Future dates are the investigator’s estimates and may change.
- Registration: October 28, 2024
History
We check the record once a month via WHO ICTRP; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Schizophrenia: guide page · Thinking of taking part? Which specialist to see